NCT04738097View on ClinicalTrials.gov

Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 8, 2021

Primary Completion Date

October 10, 2023

Study Completion Date

October 15, 2023

Conditions
Ischemic StrokeTransient Ischemic Attack
Interventions
DRUG

Ticagrelor 90mg

ASA 325 mg stat and ticagrelor 180 mg stat, then ASA 80 mg daily and ticagrelor 90 mg BID for 21 days.Treatment will be continue with ASA 80 until 3 months.

DRUG

Clopidogrel 75 mg

ASA 325 mg stat and clopidogrel 300 mg stat, then ASA 80 mg and clopidogrel 75 mg daily for 21 days.Treatment will be continue with ASA 80 until 3 months.

Trial Locations (2)

4818777111

Athena Sharifi Razavi, Sari

Unknown

Bou-Ali Sina hospital , Mazandarn University of Medical Science, Sari

All Listed Sponsors
lead

Mazandaran University of Medical Sciences

OTHER

NCT04738097 - Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke | Biotech Hunter | Biotech Hunter